BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24273003)

  • 1. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma.
    Das DK; Al-Waheeb SK; George SS; Haji BI; Mallik MK
    Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.
    Bizzarro T; Martini M; Marrocco C; D'Amato D; Traini E; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM; Rossi ED
    PLoS One; 2015; 10(7):e0132939. PubMed ID: 26186733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study.
    Addati T; Achille G; Centrone M; Petroni S; Popescu O; Russo S; Grammatica L; Simone G
    Cytopathology; 2015 Oct; 26(5):303-11. PubMed ID: 25164548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control.
    Cochand-Priollet B; Dahan H; Laloi-Michelin M; Polivka M; Saada M; Herman P; Guillausseau PJ; Hamzi L; Poté N; Sarfati E; Wassef M; Combe H; Raulic-Raimond D; Chedin P; Medeau V; Casanova D; Kania R
    Thyroid; 2011 Oct; 21(10):1067-73. PubMed ID: 21875347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential.
    Nechifor-Boilă A; Cătană R; Loghin A; Radu TG; Borda A
    Rom J Morphol Embryol; 2014; 55(1):49-56. PubMed ID: 24715165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing.
    Lee SR; Jung CK; Kim TE; Bae JS; Jung SL; Choi YJ; Kang CS
    Thyroid; 2013 Nov; 23(11):1416-22. PubMed ID: 23590130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of chemokine CXC motif ligand 12 as a novel diagnostic marker in preoperative fine-needle aspiration biopsy for papillary thyroid carcinoma.
    Jung YY; Park IA; Kim MA; Min HS; Won JK; Ryu HS
    Acta Cytol; 2013; 57(5):447-54. PubMed ID: 24021782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
    Tong J; Wang Y; Da JP
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologic features of focal papillary thyroid carcinoma arising within follicular adenoma: a masked cytomorphologic analysis of 17 cases.
    Ono JC; Wilbur DC; Lee H; Yang J; Krane JF; Bongiovanni M; Faquin WC
    Acta Cytol; 2011; 55(6):531-8. PubMed ID: 22156462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
    Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
    J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of new biomarkers and application in thyroid cytology.
    Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
    Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
    Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
    Kim MJ; Kim HJ; Hong SJ; Shong YK; Gong G
    Acta Cytol; 2006; 50(1):28-34. PubMed ID: 16514837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
    Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
    Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine needle aspiration cytology of the papillary thyroid carcinoma with a solid component: A cytological and clinical correlation.
    Ohashi R; Murase Y; Matsubara M; Watarai Y; Igarashi T; Sugitani I; Naito Z
    Diagn Cytopathol; 2017 May; 45(5):391-398. PubMed ID: 28224716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration.
    Dell'Aquila M; Gravina C; Cocomazzi A; Capodimonti S; Musarra T; Sfregola S; Fiorentino V; Revelli L; Martini M; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2019 Jun; 127(6):390-398. PubMed ID: 31135104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions.
    Aiad HA; Kandil MA; Asaad NY; El-Kased AM; El-Goday SF
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):36-46. PubMed ID: 19847280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.